March - April 2001

Go to Newsletter Archives

Nursing Home Practice:  

The MDS and Behavioral Health

Since 1991, federal regulations have required that Medicare and Medicaid certified nursing facilities perform comprehensive assessments of all residents.  The MDS (Minimum Data Set) provides the cornerstone for this assessment and is a critical element for patient care, quality improvement, and reimbursement in nursing facilities. The MDS contains more than 400 data elements.  Data included are demographic variables; clinical items (including diagnoses, syndromes, signs and symptoms, and treatments); and indicators describing cognition, behavior, mood, psychosocial well-being, and involvement in activities. The MDS identifies actual or potential problem areas for each resident and forms the foundation of development of an individualized plan of care for each resident.

The MDS is used not only to develop comprehensive assessments and plans of care for nursing facility residents, but also provides information that drives the facility survey process. The Health Care Financing Administration (HCFA) has developed nursing home Quality Indicators, derived from items on the MDS that indicate the presence or absence of potentially poor care practices or outcomes in nursing facilities. These Quality Indictors are incorporated into the nursing facility survey process. State regulatory agencies use MDS data to determine these potential areas of problems prior to an on-site survey and to identify specific residents who have these problems.  It is important to note that over 1/3 of the 24 Quality Indicators relate to behavioral health issues (see below).

The significance of the MDS to long-term care practitioners cannot be overstated. Since the MDS serves as the foundation for each resident’s care plan, the MDS can also be used as a tool in determining the medical necessity and outcome of all treatment provided.  It is essential that behavioral health practitioners in nursing facilities ensure congruity between facility comprehensive assessments and care plans and their own clinical assessments and treatment.  Practitioners should integrate MDS data into their assessments and provide input to be used by the facility care plan team during quarterly updates of MDS information in the care planning process.  Sections of the MDS which are particularly relevant to the behavioral health practitioner include Section B, Cognitive Patterns; Section C, Communicating and Understanding; Section E, Mood and Behavior Patterns; Section F, Psychosocial Well-Being; and Section N, Activity Pursuit Patterns. Comparison of responses to MDS questions at 90-day intervals offers a method of determining onset of psychiatric symptoms as well as providing an independent outcome measure during the course of treatment.


HCFA’s Quality Indicators

QI 1      Incidence of new fractures

QI 2      Prevalence of falls

QI 3      Prevalence of behavioral symptoms affecting others

QI 4      Prevalence of symptoms of depression

QI 5      Prevalence of depression with no antidepressant therapy

QI 6      Use of nine or more different medications

QI 7      Incidence of cognitive impairment

QI 8      Prevalence of bladder or bowel incontinence

QI 9      Prevalence of occasional or frequent bladder or bowel incontinence without a toileting plan

QI 10    Prevalence of indwelling catheters

QI 11    Prevalence of fecal impaction

QI 12    Prevalence of urinary tract infections

QI 13    Prevalence of weight loss
QI 14    Prevalence of tube feeding

QI 15    Prevalence of dehydration

QI 16    Prevalence of bedfast residents

QI 17    Incidence of decline in late-loss activities of daily living

QI 18    Incidence of decline in range of motion

QI 19    Prevalence of antipsychotic use in the absence of psychotic or related conditions

QI 20    Prevalence of any antianxiety/hypnotic use

QI 21    Prevalence of hypnotic use more than two times in the last week

QI 22    Prevalence of daily physical restraints

QI 23    Prevalence of little or no activity
QI 24    Prevalence of stage 1-4 pressure ulcers

 The Quality indicators in bold type directly or indirectly relate to behavioral health problems in residents and may identify the medical necessity of psychological and/or psychiatric treatment.  The large proportion (33%) of Quality Indicators involving prevalence of mental health problems indicates recognition by HCFA that good mental health is vital to good physical health.  Since Quality Indicators will be used as the starting point for your facility survey, a high quality behavioral health program should be considered an essential part of the care available to your residents.  ACT’s behavioral health program can help you enhance the quality of care for your residents and help insure regulatory compliance.

 

Psychotropic Medication Use in Nursing Facilities

HCFA OSCAR Database (12/31/98)

The figures below indicate the per cent of nursing facility residents taking each category of medications.

Psychoactive Medications

1997

1998

Overall psychoactive medicines

46.3

48.9%

Antipsychotic medicines

17.5

18.6

Antianxiety medicines

15.4

15.8

Hypnotic medicines

5.2

5.1

Antidepressant medicines

25.5

28.8

 The Resident Assessment Instrument Manual, the Health Care Financing Administration's (HCFA) guide to completing the MDS and care planning process, suggests that 35% to 65% of nursing facility residents receive psychotropic medications at one time or another.

 

 Special Events

   ACT is pleased to announce the addition of Sandra Story, PhD, to our practice.

  Happy ACT Anniversary to:

    3 years:   Dr. Bryan Patterson, Clinical Psychologist  

                   Erinn Moore, President

                   Bill Aiman, Operations Specialist

 

     1 year:   Dr. Craig Iversen, Clinical Psychologist

                  Dr. David Cook, Psychiatrist

                  Dr. "Jeff"rey Crawford, Clinical Psychologist

                  Dr. Robert "Bob" Zozus, Clinical Psychologist

  Happy Birthday to:

        Dr. Gretchen Belovicz  3/9

        Dr. Chris Norris   3/11

        Dr. Barry Moore  3/21

        Dr. Jeff Crawford  3/22

        Dr. Raveen Mehendru  4/13

        Dr. Austin Chandler  4/22

 

 

 








ACT Medical Group, PA
Corporate Office
311-4E Judges Rd.
Wilmington, NC  28405

Phone:
910-791-6767
Toll-Free:
888-311-1254
Fax:
910-791-6890
Email:
Administration

Employees Only-Intranet